Logo image of EOS

EATON VANCE ENH EQT INC II (EOS) Stock Overview

USA - NYSE:EOS - US2782771081

24.2025 USD
-0.04 (-0.15%)
Last: 9/16/2025, 8:14:26 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EOS. EOS was compared to 0 industry peers in the Unkown industry. The financial health of EOS is average, but there are quite some concerns on its profitability. EOS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

EOS had positive earnings in the past year.
EOS had a positive operating cash flow in the past year.
Of the past 5 years EOS 4 years were profitable.
EOS had a positive operating cash flow in 4 of the past 5 years.
EOS Yearly Net Income VS EBIT VS OCF VS FCFEOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 22.61%
ROE 22.69%
ROIC N/A
ROA(3y)3.3%
ROA(5y)9.6%
ROE(3y)3.3%
ROE(5y)9.67%
ROIC(3y)N/A
ROIC(5y)N/A
EOS Yearly ROA, ROE, ROICEOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

In the last couple of years the Profit Margin of EOS has grown nicely.
EOS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 4184.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y21.04%
PM growth 5Y10.18%
GM growth 3YN/A
GM growth 5YN/A
EOS Yearly Profit, Operating, Gross MarginsEOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

More info and screens

5

2. Health

2.1 Basic Checks

EOS has about the same amout of shares outstanding than it did 1 year ago.
EOS has more shares outstanding than it did 5 years ago.
EOS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EOS Yearly Shares OutstandingEOS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EOS Yearly Total Debt VS Total AssetsEOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 170.27 indicates that EOS is not in any danger for bankruptcy at the moment.
There is no outstanding debt for EOS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 170.27
ROIC/WACCN/A
WACCN/A
EOS Yearly LT Debt VS Equity VS FCFEOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

EOS has a Current Ratio of 0.22. This is a bad value and indicates that EOS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.22 indicates that EOS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
EOS Yearly Current Assets VS Current LiabilitesEOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

EOS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.30%.
EOS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.24% yearly.
Looking at the last year, EOS shows a very negative growth in Revenue. The Revenue has decreased by -12.86% in the last year.
EOS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.41% yearly.
EPS 1Y (TTM)-1.3%
EPS 3Y11.82%
EPS 5Y6.24%
EPS Q2Q%-12.22%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y-7.04%
Revenue growth 5Y-2.41%
Sales Q2Q%-10.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EOS Yearly Revenue VS EstimatesEOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.57 indicates a rather cheap valuation of EOS.
When comparing the Price/Earnings ratio of EOS to the average of the S&P500 Index (27.20), we can say EOS is valued rather cheaply.
Industry RankSector Rank
PE 4.57
Fwd PE N/A
EOS Price Earnings VS Forward Price EarningsEOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.63
EV/EBITDA N/A
EOS Per share dataEOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.73
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.48%, EOS is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.38, EOS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.48%

5.2 History

The dividend of EOS decreases each year by -0.83%.
EOS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of EOS decreased recently.
Dividend Growth(5Y)-0.83%
Div Incr Years1
Div Non Decr Years1
EOS Yearly Dividends per shareEOS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

23.10% of the earnings are spent on dividend by EOS. This is a low number and sustainable payout ratio.
DP23.1%
EPS Next 2YN/A
EPS Next 3YN/A
EOS Yearly Income VS Free CF VS DividendEOS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
EOS Dividend Payout.EOS Dividend Payout, showing the Payout Ratio.EOS Dividend Payout.PayoutRetained Earnings

More info and screens

EATON VANCE ENH EQT INC II

NYSE:EOS (9/16/2025, 8:14:26 PM)

24.2025

-0.04 (-0.15%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-25 2025-08-25
Earnings (Next)02-25 2026-02-25
Inst Owners19.29%
Inst Owner Change-0.95%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.28B
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 7.48%
Yearly Dividend1.23
Dividend Growth(5Y)-0.83%
DP23.1%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.1523)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.57
Fwd PE N/A
P/S 193.62
P/FCF 4.63
P/OCF 4.63
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)5.3
EY21.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5.23
FCFY21.61%
OCF(TTM)5.23
OCFY21.61%
SpS0.13
BVpS23.04
TBVpS23.04
PEG (NY)N/A
PEG (5Y)0.73
Profitability
Industry RankSector Rank
ROA 22.61%
ROE 22.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4184.29%
GM N/A
FCFM 4184.29%
ROA(3y)3.3%
ROA(5y)9.6%
ROE(3y)3.3%
ROE(5y)9.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y21.04%
PM growth 5Y10.18%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 100%
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z 170.27
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.3%
EPS 3Y11.82%
EPS 5Y6.24%
EPS Q2Q%-12.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y-7.04%
Revenue growth 5Y-2.41%
Sales Q2Q%-10.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-131.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.07%
FCF growth 3Y12.52%
FCF growth 5Y7.52%
OCF growth 1Y-1.07%
OCF growth 3Y12.52%
OCF growth 5Y7.52%